Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 0 | 95 | 156 | 0 | 0 |
| Gross Profit | N/A | 95 | 156 | N/A | N/A |
| Operating Expenses | 12,650 | 8,375 | 8,228 | 11,892 | 18,509 |
| Operating Income | -12,650 | -8,280 | -8,072 | -11,892 | -18,509 |
| Other Income | 3 | 3 | -7 | 2,239 | -5,261 |
| Pre-tax Income | -12,647 | -8,277 | -8,079 | -9,653 | -23,770 |
| Net Income Continuous | -12,647 | -8,277 | -8,079 | -9,653 | -23,770 |
| Net Income | $-12,647 | $-8,277 | $-8,079 | $-9,653 | $-23,770 |
| EPS Basic Total Ops | -0.75 | -4.67 | -5.48 | -10.37 | -71.60 |
| EPS Basic Continuous Ops | -0.75 | -2.95 | -5.48 | -10.37 | -71.60 |
| EPS Diluted Total Ops | -0.75 | -4.67 | -5.48 | -10.37 | -71.60 |
| EPS Diluted Continuous Ops | -0.75 | -2.95 | -5.48 | -10.37 | -71.60 |
| EBITDA(a) | $-12,541 | $-8,170 | $-7,945 | $-11,742 | $-18,315 |